American Electric Power Company Inc vs BioNano Genomics Inc — how do they compare? American Electric Power Company Inc trades at $123.69 (market cap $67.28B), while BioNano Genomics Inc trades at $1.18 (market cap $13.66M). The key difference: American Electric Power Company Inc is far larger — about 4925.3× BioNano Genomics Inc's market cap, and American Electric Power Company Inc pays a 3.07% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| AEP | BNGO | |
|---|---|---|
Market Cap | $67.28B | $13.66M |
Sector | Utilities | Health |
52-Week High | $138.69 | $4.92 |
52-Week Low | $106.44 | $1.06 |
Enterprise Value | $120.17B | $16.26M |
Dividend Yield | 3.07% | — |
Signals from Pluang's Aura AI — not financial advice
AEP trades at $124.17, up 1.08% today, with a bearish technical signal but strong fundamentals. Recent Q2 2026 EPS missed estimates at $1.36 versus $1.48 expected, yet revenue grew 7% year-over-year. The company raised 2026 operating EPS guidance to $6.25–$6.55, supported by a $78 billion capital plan and 69 GW of contracted load growth. Analyst consensus is bullish with a $140.89 price target, and dividends remain stable with a $0.95 payment scheduled for September 2026.
Outlook is positive due to robust demand from data centers and regulatory progress, but risks include high debt levels and interest expenses. The stock offers growth potential from AI-driven electricity demand, though valuation premiums and execution risks warrant caution. Near-term support lies at $121, with resistance at $126.
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
Trailing returns across standard periods
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →